NASDAQ: CCAP
Crescent Capital Bdc Inc Stock

$15.97-0.22 (-1.36%)
Updated Apr 30, 2025
CCAP Price
$15.97
Fair Value Price
$3.30
Market Cap
$591.87M
52 Week Low
$13.54
52 Week High
$20.19
P/E
8.03x
P/B
0.8x
P/S
3.61x
PEG
2.92x
Dividend Yield
9.89%
Revenue
$197.36M
Earnings
$73.65M
Gross Margin
48.5%
Operating Margin
38.1%
Profit Margin
37.3%
Debt to Equity
1.24
Operating Cash Flow
$59M
Beta
0.44
Next Earnings
May 7, 2025
Ex-Dividend
N/A
Next Dividend
N/A

CCAP Overview

Crescent Capital BDC, Inc. is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine CCAP's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Asset Management

Industry Rating
D
CCAP
Ranked
#47 of 85

Top Ranked Stocks in Industry

View Top Asset Management Stocks

Be the first to know about important CCAP news, forecast changes, insider trades & much more!

CCAP News

Overview

Due Diligence Score

Industry Average (34)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CCAP scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CCAP ($15.97) is overvalued by 383.24% relative to our estimate of its Fair Value price of $3.30 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
CCAP ($15.97) is not significantly undervalued (383.24%) relative to our estimate of its Fair Value price of $3.30 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CCAP ($15.97) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more CCAP due diligence checks available for Premium users.

Valuation

CCAP fair value

Fair Value of CCAP stock based on Discounted Cash Flow (DCF)

Price
$15.97
Fair Value
$3.30
Overvalued by
383.24%
CCAP ($15.97) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CCAP ($15.97) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CCAP ($15.97) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CCAP price to earnings (PE)

For valuing profitable companies with steady earnings

Company
8.03x
Industry
35.77x
Market
29.18x
CCAP is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CCAP is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

CCAP price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
0.8x
Industry
2.66x
CCAP is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CCAP price to earnings growth (PEG)

For valuing profitable companies with growth potential

CCAP is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

CCAP's financial health

Profit margin

Revenue
$46.4M
Net Income
$10.0M
Profit Margin
21.5%
CCAP's Earnings (EBIT) of $75.20M... subscribe to Premium to read more.
Interest Coverage Financials
CCAP's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$1.7B
Liabilities
$915.6M
Debt to equity
1.24
CCAP's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CCAP's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.9M
Investing
$0.0
Financing
$5.0M
CCAP's operating cash flow ($58.91M)... subscribe to Premium to read more.
Debt Coverage Financials

CCAP vs Asset Management Stocks

TickerZen RatingMarket Cap1d %P/EP/B
CCAPC$591.87M-1.36%8.03x0.80x
TCPCC$581.93M-2.01%-8.66x0.74x
NOAHC$616.01M-1.61%9.88x0.45x
VINPC$617.41M-0.41%26.20x1.85x
GLADC$557.13M-1.77%5.39x1.16x

Crescent Capital Bdc Stock FAQ

What is Crescent Capital Bdc's quote symbol?

(NASDAQ: CCAP) Crescent Capital Bdc trades on the NASDAQ under the ticker symbol CCAP. Crescent Capital Bdc stock quotes can also be displayed as NASDAQ: CCAP.

If you're new to stock investing, here's how to buy Crescent Capital Bdc stock.

What is the 52 week high and low for Crescent Capital Bdc (NASDAQ: CCAP)?

(NASDAQ: CCAP) Crescent Capital Bdc's 52-week high was $20.19, and its 52-week low was $13.54. It is currently -20.9% from its 52-week high and 17.95% from its 52-week low.

How much is Crescent Capital Bdc stock worth today?

(NASDAQ: CCAP) Crescent Capital Bdc currently has 37,061,547 outstanding shares. With Crescent Capital Bdc stock trading at $15.97 per share, the total value of Crescent Capital Bdc stock (market capitalization) is $591.87M.

Crescent Capital Bdc stock was originally listed at a price of $16.40 in Feb 3, 2020. If you had invested in Crescent Capital Bdc stock at $16.40, your return over the last 5 years would have been -2.62%, for an annualized return of -0.53% (not including any dividends or dividend reinvestments).

How much is Crescent Capital Bdc's stock price per share?

(NASDAQ: CCAP) Crescent Capital Bdc stock price per share is $15.97 today (as of Apr 30, 2025).

What is Crescent Capital Bdc's Market Cap?

(NASDAQ: CCAP) Crescent Capital Bdc's market cap is $591.87M, as of May 1, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Crescent Capital Bdc's market cap is calculated by multiplying CCAP's current stock price of $15.97 by CCAP's total outstanding shares of 37,061,547.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.